LOS ANGELES, Nov. 29, 2022 /PRNewswire/ -- AmyriAD Therapeutics (AmyriAD) a privately held, late clinical-stage pharmaceutical development company focused on advancing therapies for Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results